252 related articles for article (PubMed ID: 30094858)
1. Effect of selective versus nonselective cyclooxygenase inhibitors on gastric ulceration scores and intestinal inflammation in horses.
Richardson LM; Whitfield-Cargile CM; Cohen ND; Chamoun-Emanuelli AM; Dockery HJ
Vet Surg; 2018 Aug; 47(6):784-791. PubMed ID: 30094858
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of selective and non-selective cyclooxygenase inhibitors on fecal microbiota in adult horses.
Whitfield-Cargile CM; Chamoun-Emanuelli AM; Cohen ND; Richardson LM; Ajami NJ; Dockery HJ
PLoS One; 2018; 13(8):e0202527. PubMed ID: 30138339
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the safety of a combination of oral administration of phenylbutazone and firocoxib in horses.
Kivett L; Taintor J; Wright J
J Vet Pharmacol Ther; 2014 Aug; 37(4):413-6. PubMed ID: 24354928
[TBL] [Abstract][Full Text] [Related]
4. Effects of phenylbutazone alone or in combination with a nutritional therapeutic on gastric ulcers, intestinal permeability, and fecal microbiota in horses.
Whitfield-Cargile CM; Coleman MC; Cohen ND; Chamoun-Emanuelli AM; DeSolis CN; Tetrault T; Sowinski R; Bradbery A; Much M
J Vet Intern Med; 2021 Mar; 35(2):1121-1130. PubMed ID: 33656183
[TBL] [Abstract][Full Text] [Related]
5. Impact of concurrent treatment with omeprazole on phenylbutazone-induced equine gastric ulcer syndrome (EGUS).
Ricord M; Andrews FM; Yñiguez FJM; Keowen M; Garza F; Paul L; Chapman A; Banse HE
Equine Vet J; 2021 Mar; 53(2):356-363. PubMed ID: 32697849
[TBL] [Abstract][Full Text] [Related]
6. Update on the use of cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs in horses.
Ziegler A; Fogle C; Blikslager A
J Am Vet Med Assoc; 2017 Jun; 250(11):1271-1274. PubMed ID: 28509650
[TBL] [Abstract][Full Text] [Related]
7. Effects of Firocoxib, Flunixin Meglumine, and Phenylbutazone on Platelet Function and Thromboxane Synthesis in Healthy Horses.
Burkett BN; Thomason JM; Hurdle HM; Wills RW; Fontenot RL
Vet Surg; 2016 Nov; 45(8):1087-1094. PubMed ID: 27731498
[TBL] [Abstract][Full Text] [Related]
8. Phenylbutazone induces equine glandular gastric disease without decreasing prostaglandin E
Pedersen SK; Cribb AE; Read EK; French D; Banse HE
J Vet Pharmacol Ther; 2018 Apr; 41(2):239-245. PubMed ID: 29148168
[TBL] [Abstract][Full Text] [Related]
9. Effects of phenylbutazone on gene expression of cyclooxygenase-1 and -2 in the oral, glandular gastric, and bladder mucosae of healthy horses.
Nieto JE; Aleman M; Anderson JD; Fiack C; Snyder JR
Am J Vet Res; 2012 Jan; 73(1):98-104. PubMed ID: 22204294
[TBL] [Abstract][Full Text] [Related]
10. Effect of flunixin meglumine and firocoxib on ex vivo cyclooxygenase activity in horses undergoing elective surgery.
Duz M; Parkin TD; Cullander RM; Marshall JF
Am J Vet Res; 2015 Mar; 76(3):208-15. PubMed ID: 25710756
[TBL] [Abstract][Full Text] [Related]
11. Periovulatory administration of firocoxib did not alter ovulation rates and mitigated post-breeding inflammatory response in mares.
Friso AM; Segabinazzi LGTM; Cyrino M; Correal SB; Freitas-Dell'Aqua CP; Teoro do Carmo M; Dell'Aqua JA; Miró J; Papa FO; Alvarenga MA
Theriogenology; 2019 Oct; 138():24-30. PubMed ID: 31280182
[TBL] [Abstract][Full Text] [Related]
12. Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis.
Doucet MY; Bertone AL; Hendrickson D; Hughes F; Macallister C; McClure S; Reinemeyer C; Rossier Y; Sifferman R; Vrins AA; White G; Kunkle B; Alva R; Romano D; Hanson PD
J Am Vet Med Assoc; 2008 Jan; 232(1):91-7. PubMed ID: 18167116
[TBL] [Abstract][Full Text] [Related]
13. Preferential and non-selective cyclooxygenase inhibitors reduce inflammation during lipopolysaccharide-induced synovitis.
Morton AJ; Campbell NB; Gayle JM; Redding WR; Blikslager AT
Res Vet Sci; 2005 Apr; 78(2):189-92. PubMed ID: 15563928
[TBL] [Abstract][Full Text] [Related]
14. Effect of firocoxib or flunixin meglumine on recovery of ischemic-injured equine jejunum.
Cook VL; Meyer CT; Campbell NB; Blikslager AT
Am J Vet Res; 2009 Aug; 70(8):992-1000. PubMed ID: 19645580
[TBL] [Abstract][Full Text] [Related]
15. Multicentre, blinded, randomised clinical trial comparing the use of flunixin meglumine with firocoxib in horses with small intestinal strangulating obstruction.
Ziegler AL; Freeman CK; Fogle CA; Burke MJ; Davis JL; Cook VL; Southwood LL; Blikslager AT
Equine Vet J; 2019 May; 51(3):329-335. PubMed ID: 30156312
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of oral administration of firocoxib for the management of musculoskeletal pain and lameness associated with osteoarthritis in horses.
Orsini JA; Ryan WG; Carithers DS; Boston RC
Am J Vet Res; 2012 May; 73(5):664-71. PubMed ID: 22533398
[TBL] [Abstract][Full Text] [Related]
17. A comparison of two doses of omeprazole in the treatment of equine gastric ulcer syndrome: a blinded, randomised, clinical trial.
Sykes BW; Sykes KM; Hallowell GD
Equine Vet J; 2014 Jul; 46(4):416-21. PubMed ID: 24102898
[TBL] [Abstract][Full Text] [Related]
18. Distribution of flunixin meglumine and firocoxib into aqueous humor of horses.
Hilton HG; Magdesian KG; Groth AD; Knych H; Stanley SD; Hollingsworth SR
J Vet Intern Med; 2011; 25(5):1127-33. PubMed ID: 21781166
[TBL] [Abstract][Full Text] [Related]
19. Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses.
Reed SK; Messer NT; Tessman RK; Keegan KG
Am J Vet Res; 2006 Mar; 67(3):398-402. PubMed ID: 16506899
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of cyclo-oxygenase inhibition by two commercially available firocoxib products in horses.
Barton MH; Paske E; Norton N; King D; Giguère S; Budsberg S
Equine Vet J; 2014 Jan; 46(1):72-5. PubMed ID: 23662599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
